课题基金 / 基金详情

Development of the drug which prevents the induction of acute renal failure and its clinical application

Development of the drug which prevents the induction of acute renal failure and its clinical application
预防急性肾功能衰竭药物的研制及其临床应用
批准号:
05557053
负责人:
MARUMO Fumiaki
金额:
$7.55万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

MARUMO Fumiaki的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在阐明内皮素(ET)及其受体在急性肾功能衰竭进展中的作用,并开发抑制ET作用的急性肾功能衰竭预防药物。在阐明ET在急性肾功能衰竭中的作用方面,研究取得了较好的进展。ET3几乎在肾脏的所有部位都有表达,提示其在肾脏功能中的重要作用(文献1)。集管细胞的ET1产生受到许多刺激,如高渗透压(参考文献2)。ET3刺激肾小球系膜细胞的NO合成,从而刺激cGMP的产生。这些事件证实了ET在肾脏功能调节中的重要性。基于这些发现,我们试图培养抗ET受体(主要是ETA受体)的抗体来抑制ET的作用。我们用几种不同的方法对兔子进行免疫,并获得了一些抗体。然而,这些抗体都不能抑制ET在肾功能中的作用,尽管其中一些抗体能识别受体。一般来说,获得一种良好的疏水激素受体抗体是非常困难的。我们应该进一步努力获得一种好的抗体,但也可以考虑其他方法。
英文摘要
In this research, we intended t o clarify the role of entothelins (ET) and their receptors in the progression of acute renal failure, and to develop the priventive drug for acute renal failure which inhibits the action of ET.The research has been performed well in respect of clarifying the role of ET in acute renal failure. ET3 is expressed in almost all parts of the kidney, suggesting its important role in kidney function (Ref.1). ET1 production in collectiong duct cells is subjects to many stimulus such as hyperosmolality (Ref.2). ET3 stimulates NO synthesis in glomerular mesangial cells which in turn stimulats cGMP production. These events establish the importance of ET in regulation of kidney functions.Based on these findings we have tried to raise antibodies against ET receptors (mainly, ETA recptor) which inhibits ET action. We immunized rabbits using several different methods, and obtained a number of antibodies. However, none of these antibodies inhibited the action of ET in kidney fuunction, although some of them recongnised the receptors. It is a general rule that obtaining a good antibody for hydrophobic hormone receptor is extremely difficult. We should try further to obtain a good antibody, but alternative approaches may be considered.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Owada A.et al.: "Endothelin(ET)-3 stimulates cyclic guanosine 3n,5′5-monophosphate production via ETb receptor by producing nitric oxide in isolated rat glomerulus,and in cultured rat mesangial cells." J. Clin. Invest. 93. 556-563 (1994)
Owada A. 等人:“内皮素 (ET)-3 通过 ETb 受体在离体大鼠肾小球和培养的大鼠系膜细胞中产生一氧化氮,从而刺激环鸟苷 3n,55-单磷酸的产生。” . 93. 556-563 (1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Terada Y.et al: "Localization of type-1 AT-II receptor mRNA in rat nephron segments" Kidney Int. 43. 1251-1259 (1993)
Terada Y.et al:“大鼠肾单位片段中 1 型 AT-II 受体 mRNA 的定位”Kidney Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
22
    Molecular Cell Biological Studies of Kidney Membrane Transporter Diseases.
    • 批准号:
      09102007
    • 项目类别:
      Grant-in-Aid for Specially Promoted Research
    • 资助金额:
      $174.72万
    • 财政年份:
      1997
    • 负责人:
      MARUMO Fumiaki
    • 依托单位:
    Urine concentrating mechanisms examined by molecular biology based techniques
    • 批准号:
      06404041
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $26.11万
    • 财政年份:
      1994
    • 负责人:
      MARUMO Fumiaki
    • 依托单位:
    Molecular Biology of the Kidney-Molecular Analysis of Structure and Function Relationship
    • 批准号:
      05304037
    • 项目类别:
      Grant-in-Aid for Co-operative Research (A)
    • 资助金额:
      $1.54万
    • 财政年份:
      1993
    • 负责人:
      MARUMO Fumiaki
    • 依托单位:
    Study on Autoregulatory Mechanism of Body Fluid with Special Emphasis on Kidney and Hormones
    • 批准号:
      02304055
    • 项目类别:
      Grant-in-Aid for Co-operative Research (A)
    • 资助金额:
      $2.56万
    • 财政年份:
      1990
    • 负责人:
      MARUMO Fumiaki
    • 依托单位:
    国内基金
    海外基金
    Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
    • 批准号:
      81300605
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2013
    • 负责人:
      唐琳
    • 依托单位: